Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis

Abstract Background Antibodies binding to cartilage proteins are present in the blood and synovial fluid of early rheumatoid arthritis patients. In order to develop animal models mimicking the human disease, we have characterized the arthritogenic capacity of monoclonal antibodies directed towards d...

Full description

Bibliographic Details
Main Authors: Yanpeng Li, Dongmei Tong, Peibin Liang, Erik Lönnblom, Johan Viljanen, Bingze Xu, Kutty Selva Nandakumar, Rikard Holmdahl
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13075-020-02169-0
_version_ 1819152769735458816
author Yanpeng Li
Dongmei Tong
Peibin Liang
Erik Lönnblom
Johan Viljanen
Bingze Xu
Kutty Selva Nandakumar
Rikard Holmdahl
author_facet Yanpeng Li
Dongmei Tong
Peibin Liang
Erik Lönnblom
Johan Viljanen
Bingze Xu
Kutty Selva Nandakumar
Rikard Holmdahl
author_sort Yanpeng Li
collection DOAJ
description Abstract Background Antibodies binding to cartilage proteins are present in the blood and synovial fluid of early rheumatoid arthritis patients. In order to develop animal models mimicking the human disease, we have characterized the arthritogenic capacity of monoclonal antibodies directed towards different joint proteins in the cartilage. Methods Purified antibodies specific to unmodified or citrullinated collagen type II (CII), collagen type XI (CXI), and cartilage oligomeric matrix protein (COMP) were produced as culture supernatant, affinity purified, pooled as antibody cocktails (Cab3 and Cab4), and injected intravenously into mice to induce arthritis. An adjuvant (lipopolysaccharide or mannan) was subsequently injected intraperitoneally on either day 5 or day 60 to enhance arthritis. Antibody binding and complement activation on the cartilage surface were analyzed by immunohistochemical methods. Bone erosions and joint deformations were analyzed by histological assessments, enzyme-linked immunosorbent assays, and micro-CT. Luminex was used to detect CII-triple helical epitope-specific antibody responses. Results The new cartilage antibody cocktails induced an earlier and more severe disease than anti-CII antibody cocktail. Many of the mouse strains used developed severe arthritis with 3 antibodies, binding to collagen II, collagen XI, and cartilage oligomeric matrix protein (the Cab3 cocktail). Two new models of arthritis including Cab3-induced LPS-enhanced arthritis (lpsCAIA) and Cab3-induced mannan-enhanced arthritis (mCAIA) were established, causing severe bone erosions and bone loss, as well as epitope spreading of the B cell response. Cab4, with addition of an antibody to citrullinated collagen II, induced arthritis more efficiently in moderately susceptible C57BL/6 J mice. Conclusions The new mouse model for RA induced with cartilage antibodies allows studies of chronic development of arthritis and epitope spreading of the autoimmune response and bone erosion.
first_indexed 2024-12-22T14:54:34Z
format Article
id doaj.art-59ac9ab6e47e4d6eb819447b501623b6
institution Directory Open Access Journal
issn 1478-6362
language English
last_indexed 2024-12-22T14:54:34Z
publishDate 2020-05-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj.art-59ac9ab6e47e4d6eb819447b501623b62022-12-21T18:22:14ZengBMCArthritis Research & Therapy1478-63622020-05-0122111410.1186/s13075-020-02169-0Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritisYanpeng Li0Dongmei Tong1Peibin Liang2Erik Lönnblom3Johan Viljanen4Bingze Xu5Kutty Selva Nandakumar6Rikard Holmdahl7SMU-KI United Medical Inflammation Center, School of Pharmaceutical Sciences, Southern Medical UniversityMedical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska InstituteSMU-KI United Medical Inflammation Center, School of Pharmaceutical Sciences, Southern Medical UniversityMedical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska InstituteDepartment of Chemistry Biomedical Center, Uppsala UniversityMedical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska InstituteSMU-KI United Medical Inflammation Center, School of Pharmaceutical Sciences, Southern Medical UniversitySMU-KI United Medical Inflammation Center, School of Pharmaceutical Sciences, Southern Medical UniversityAbstract Background Antibodies binding to cartilage proteins are present in the blood and synovial fluid of early rheumatoid arthritis patients. In order to develop animal models mimicking the human disease, we have characterized the arthritogenic capacity of monoclonal antibodies directed towards different joint proteins in the cartilage. Methods Purified antibodies specific to unmodified or citrullinated collagen type II (CII), collagen type XI (CXI), and cartilage oligomeric matrix protein (COMP) were produced as culture supernatant, affinity purified, pooled as antibody cocktails (Cab3 and Cab4), and injected intravenously into mice to induce arthritis. An adjuvant (lipopolysaccharide or mannan) was subsequently injected intraperitoneally on either day 5 or day 60 to enhance arthritis. Antibody binding and complement activation on the cartilage surface were analyzed by immunohistochemical methods. Bone erosions and joint deformations were analyzed by histological assessments, enzyme-linked immunosorbent assays, and micro-CT. Luminex was used to detect CII-triple helical epitope-specific antibody responses. Results The new cartilage antibody cocktails induced an earlier and more severe disease than anti-CII antibody cocktail. Many of the mouse strains used developed severe arthritis with 3 antibodies, binding to collagen II, collagen XI, and cartilage oligomeric matrix protein (the Cab3 cocktail). Two new models of arthritis including Cab3-induced LPS-enhanced arthritis (lpsCAIA) and Cab3-induced mannan-enhanced arthritis (mCAIA) were established, causing severe bone erosions and bone loss, as well as epitope spreading of the B cell response. Cab4, with addition of an antibody to citrullinated collagen II, induced arthritis more efficiently in moderately susceptible C57BL/6 J mice. Conclusions The new mouse model for RA induced with cartilage antibodies allows studies of chronic development of arthritis and epitope spreading of the autoimmune response and bone erosion.http://link.springer.com/article/10.1186/s13075-020-02169-0Rheumatoid arthritisCartilageAnimal modelsAntibodiesCollagen
spellingShingle Yanpeng Li
Dongmei Tong
Peibin Liang
Erik Lönnblom
Johan Viljanen
Bingze Xu
Kutty Selva Nandakumar
Rikard Holmdahl
Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
Arthritis Research & Therapy
Rheumatoid arthritis
Cartilage
Animal models
Antibodies
Collagen
title Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
title_full Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
title_fullStr Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
title_full_unstemmed Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
title_short Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
title_sort cartilage binding antibodies initiate joint inflammation and promote chronic erosive arthritis
topic Rheumatoid arthritis
Cartilage
Animal models
Antibodies
Collagen
url http://link.springer.com/article/10.1186/s13075-020-02169-0
work_keys_str_mv AT yanpengli cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis
AT dongmeitong cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis
AT peibinliang cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis
AT eriklonnblom cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis
AT johanviljanen cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis
AT bingzexu cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis
AT kuttyselvanandakumar cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis
AT rikardholmdahl cartilagebindingantibodiesinitiatejointinflammationandpromotechronicerosivearthritis